Safety and Immunogenicity of Heterologous Prime-boost With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP in Healthy Adults in a Malaria Endemic Area.
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2012
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; ME-TRAP malaria DNA vaccine Okairos (Primary)
- Indications Malaria
- Focus Adverse reactions
- 02 Oct 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 15 Jun 2012 Actual end date May 2011 added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.